Europe warms to Russian jab after positive trial results

Paris (AFP) – Final-stage trial results published on Tuesday placed Russia’s Sputnik V coronavirus vaccine on a par with its Western rivals, as German Chancellor Angela Merkel voiced openness to its use in the European Union once it receives the regulatory nod. Sputnik V, which has already been rolled out in Russia and several other countries, was found to be 91.6 percent effective against symptomatic Covid-19 cases in trial results published by The Lancet, a leading medical journal. “There are no arguments left for critics of this vaccine, the article in The Lancet is a checkmate,” said Kiril…

Read More

HEDGE accordingly